Systems and methods to identify a subgroup of ADHD at higher risk for complicating conditions

• US 8,509,884 B2
• Filed: 08/27/2010
• Issued: 08/13/2013
• Est. Priority Date: 08/28/2009
• Status: Expired due to Fees

• Current Assignee: NEBA Health, LLC
• Original Assignee: NEBA Health, LLC
• Inventors: Snyder, Steven M.
• Primary Examiner(s): Mallari, Patricia
• Assistant Examiner(s): BERHANU, ETSUB D
• Application Number:
  US12/870,328
• Publication Number:
  US 20110066065A1
• Time in Patent Office: 1,082 Days
• Field of Search: 600/544, 434/236
• US Class Current: 600/544
• CPC Class Codes: A61B 5/0006 ECG or EEG signals
• CPC Class Codes: A61B 5/0022 Monitoring a patient using a global network, e.g. telephone networks, internet
• CPC Class Codes: A61B 5/168 Evaluating attention deficit, hyperactivity
• CPC Class Codes: A61B 5/316 Modalities, i.e. specific diagnostic methods
• CPC Class Codes: A61B 5/369 Electroencephalography [EEG] devices for psychotechnics A61B5/16
• CPC Class Codes: G16H 50/20 for computer-aided diagnosis, e.g. based on medical expert systems
• CPC Class Codes: Y02A 90/10 Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Abstract

This invention is directed to embodiments of systems and methods to identify a subgroup of ADHD at higher risk for complicating conditions that, for example, may be of concern to an ADHD evaluation, may account for attention and behavior symptoms, and may lead a clinician to exclusion of ADHD from primary diagnosis. In one embodiment, a method for identifying a subgroup of attention deficit hyperactivity disorder (ADHD) patients at higher risk for complicating conditions is provided. The method can include receiving, from a user or clinician, evaluation data associated with a plurality of patients identified with ADHD as a primary diagnosis; obtaining EEG data for each of the plurality of patients; determining, based at least in part on the EEG data, an indicator of ADHD, wherein the indicator supports a positive or negative ADHD evaluation; correlating the indicator with a user'"'"'s or clinician'"'"'s evaluation data; and based at least in part on the correlation, determining at least one subgroup of the plurality of patients, wherein the correlation provides positive support for diagnosis of ADHD or provides support for further testing for complicating conditions before proceeding with diagnosis of ADHD in at least one patient within the at least one subgroup.

Claims

1. A system for identifying a subgroup of attention deficit hyperactivity disorder (ADHD) patients at higher risk for complicating conditions, the system comprising:

a data collection module operable to;

receive, from a user or clinician, evaluation data associated with a plurality of patients identified with ADHD as a primary diagnosis; and

obtain EEG data for each of the plurality of patients;

a clinical/diagnostic module operable to;

based at least in part on the EEG data, determine an indicator of ADHD, wherein the indicator supports a positive or negative ADHD evaluation; and

a subgroup identification module operable to;

correlate the indicator with the user'"'"'s or clinician'"'"'s evaluation data; and

based at least in part on the correlation, determine at least one subgroup of the plurality of patients, wherein the correlation provides positive support for diagnosis of ADHD or provides support for further testing for complicating conditions before proceeding with diagnosis of ADHD in at least one patient within the at least one subgroup.

2. The system of claim 1, wherein determining at least one subgroup of the plurality of patients comprises determining a first subgroup receiving positive support, and a second subgroup receiving a recommendation for further testing.

3. The system of claim 2, wherein the at least one subgroup comprises a subgroup receiving a recommendation for further testing, and the subgroup identification module is further operable to:

obtain further clinical data to determine whether one or more complicating conditions are present which could exclude ADHD as the primary diagnosis.

4. The system of claim 1, wherein the subgroup identification module is further operable to:

provide a graded recommendation for any patients receiving support for further testing for complicating conditions before proceeding with diagnosis of ADHD.

5. The system of claim 1, wherein the EEG data comprises at least one theta/beta ratio calculation, or a ratio computed by dividing average percent power in the theta frequency band by average percent power in the beta frequency band.

6. The system of claim 1, wherein the correlation comprises a theta/beta ratio calculation within a predefined range, and wherein the correlation provides:

(i) positive support for diagnosis of ADHD, (ii) a suggestion for further testing for complicating conditions before proceeding with diagnosis of ADHD or, (iii) a strong recommendation for further testing for complicating conditions before proceeding with diagnosis of ADHD in at least one patient within a predefined age range within the at least one subgroup.

7. The system of claim 1, further comprising:

a report module operable to;

output an indication for at least one patient within the at least one subgroup, wherein the indication corresponds to whether the correlation provides positive support for diagnosis of ADHD or provides support for further testing for complicating conditions before proceeding with diagnosis of ADHD in the at least one patient.

8. A computer program product, comprising a computer readable medium having computer readable code adapted to be executed to implement a method for identifying a subgroup of attention deficit hyperactivity disorder (ADHD) patients at higher risk for complicating conditions, the method comprising:

receiving, from a user or clinician, evaluation data associated with a plurality of patients identified with ADHD as a primary diagnosis;

obtaining, via the data collection module, EEG data for each of the plurality of patients;

based at least in part on the EEG data, determining an indicator of ADHD via the clinical/diagnostic module, wherein the indicator supports a positive or negative ADHD evaluation;

correlating the indicator with the user'"'"'s or clinician'"'"'s evaluation data; and

based at least in part on the correlation, determining, via the subgroup identification module, at least one subgroup of the plurality of patients, wherein the correlation provides positive support for diagnosis of ADHD or provides support of further testing for complicating conditions before proceeding with diagnosis of ADHD in at least one patient within the at least one subgroup.

9. The computer program product of claim 8, wherein determining at least one subgroup of the plurality of patients comprises determining a first subgroup receiving positive support, and a second subgroup receiving a recommendation for further testing.

10. The computer program product of claim 9, wherein the at least one subgroup comprises a subgroup receiving a recommendation for further testing, and the method further comprises:

obtaining further clinical data to determine whether one or more complicating conditions are present which could exclude ADHD as the primary diagnosis.

11. The computer program product of claim 8, wherein the method further comprises:

providing, via the subgroup identification module, a graded recommendation for any patients receiving support for further testing for complicating conditions before proceeding with diagnosis of ADHD.

12. The computer program product of claim 8, wherein the EEG data comprises at least one theta/beta ratio calculation, or a ratio computed by dividing average percent power in the theta frequency band by average percent power in the beta frequency band.

13. The computer program product of claim 8, wherein the correlation comprises a theta/beta ratio calculation within a predefined range, and wherein the correlation provides:

(i) positive support for diagnosis of ADHD, (ii) a suggestion for further testing for complicating conditions before proceeding with diagnosis of ADHD or, (iii) a strong recommendation for further testing for complicating conditions before proceeding with diagnosis of ADHD in at least one patient within a predefined age range within the at least one subgroup.

14. The computer program product of claim 8, wherein the method further comprises:

outputting, via a report module, an indication for at least one patient within the at least one subgroup, wherein the indication corresponds to whether the correlation provides positive support for diagnosis of ADHD or provides support for further testing for complicating conditions before proceeding with diagnosis of ADHD in the at least one patient.

15. A computer-implemented method for identifying a subgroup of attention deficit hyperactivity disorder (ADHD) patients at risk for complicating conditions, the method comprising:

using a data collection module, receiving, from a user or clinician, evaluation data associated with a plurality of patients identified with ADHD as a primary diagnosis; and

obtaining EEG data for each of the plurality of patients;

using a clinical/diagnostic module, based at least in part on the EEG data, determining an indicator of ADHD, wherein the indicator supports a positive or negative ADHD evaluation; and

using a subgroup identification module, correlating the indicator with the user'"'"'s or clinician'"'"'s evaluation data; and

based at least in part on the correlation, determining at least one subgroup of the plurality of patients, wherein the correlation provides positive support for diagnosis of ADHD or provides support for further testing for complicating conditions before proceeding with diagnosis of ADHD in at least one patient within the at least one subgroup.

16. The method of claim 15, wherein the correlation comprises a theta/beta ratio calculation within a predefined range, and wherein the correlation provides:

(i) positive support for diagnosis of ADHD, (ii) a suggestion for further testing for complicating conditions before proceeding with diagnosis of ADHD or, (iii) a strong recommendation for further testing for complicating conditions before proceeding with diagnosis of ADHD in at least one patient within a predefined age range within the at least one subgroup.

17. The method of claim 16, wherein the at least one subgroup comprises a subgroup receiving a recommendation for further testing, and the method further comprises:

obtaining further clinical data to determine whether one or more complicating conditions are present which could exclude ADHD as the primary diagnosis.

18. The method of claim 16, further comprising:

providing a graded recommendation for any patients receiving support for further testing for complicating conditions before proceeding with diagnosis of ADHD.

19. The method of claim 16, wherein the EEG data comprises either at least one theta/beta ratio calculation, or a ratio computed by dividing average percent power in the theta frequency band by average percent power in the beta frequency band.

20. The method of claim 16, further comprising:

outputting an indication for at least one patient within the at least one subgroup, wherein the indication corresponds to whether the correlation provides positive support for diagnosis of ADHD or provides support for further testing for complicating conditions before proceeding with diagnosis of ADHD in the at least one patient.